Regeneron and Sanofi's $37,000 per year eczema mAb given US FDA nod
The US FDA has approved the first systematic treatment for eczema: Sanofi and Regeneron’ monoclonal antibody Dupixent (dupilumab).
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs